Cargando…
Clinical Trial Highlights – GLP-1 agonists
Autores principales: | McFarthing, Kevin, Larson, Danielle, Simuni, Tanya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242848/ https://www.ncbi.nlm.nih.gov/pubmed/32250322 http://dx.doi.org/10.3233/JPD-200002 |
Ejemplares similares
-
CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON’S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA’S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES
por: McFarthing, Kevin, et al.
Publicado: (2019) -
CLINICAL TRIAL HIGHLIGHTS – DYSKINESIA
por: McFarthing, Kevin, et al.
Publicado: (2019) -
Clinical Trial Highlights – Infusion Therapies
por: Prakash, Neha, et al.
Publicado: (2020) -
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update
por: McFarthing, Kevin, et al.
Publicado: (2022) -
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update
por: McFarthing, Kevin, et al.
Publicado: (2023)